日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

Divarasib联合西妥昔单抗治疗KRAS G12C阳性结直肠癌:一项1b期试验

Desai, Jayesh; Alonso, Guzman; Kim, Se Hyun; Cervantes, Andres; Karasic, Thomas; Medina, Laura; Shacham-Shmueli, Einat; Cosman, Rasha; Falcon, Alejandro; Gort, Eelke; Guren, Tormod; Massarelli, Erminia; Miller, Wilson H Jr; Paz-Ares, Luis; Prenen, Hans; Amatu, Alessio; Cremolini, Chiara; Kim, Tae Won; Moreno, Victor; Ou, Sai-Hong I; Passardi, Alessandro; Sacher, Adrian; Santoro, Armando; Stec, Rafal; Ulahannan, Susanna; Arbour, Kathryn; Lorusso, Patricia; Luo, Jia; Patel, Manish R; Choi, Yoonha; Shi, Zhen; Mandlekar, Sandhya; Lin, Mark T; Royer-Joo, Stephanie; Chang, Julie; Jun, Tomi; Dharia, Neekesh V; Schutzman, Jennifer L; Han, Sae-Won

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors

TPST-1120(一种 PPARα 抑制剂)作为单药疗法或与纳武利尤单抗联合疗法治疗晚期实体瘤患者的首次人体 I 期试验

Yarchoan, Mark; Powderly, John D; Bastos, Bruno R; Karasic, Thomas B; Crysler, Oxana V; Munster, Pamela N; McKean, Meredith A; Emens, Leisha A; Saenger, Yvonne M; Ged, Yasser; Stagg, Robert; Smith, Steven; Whiting, Chan C; Moon, Anne; Prasit, Peppi; Jenkins, Yonchu; Standifer, Nathan; Dubensky, Thomas W; Whiting, Sam H; Ulahannan, Susanna V

Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab

利用分类回归树预测接受阿特珠单抗和贝伐珠单抗治疗的肝细胞癌患者的生存期

Brown, Timothy J; Gimotty, Phyllis A; Mamtani, Ronac; Karasic, Thomas B; Yang, Yu-Xiao

Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer

FOENIX-CCA2 研究简明摘要:富巴替尼治疗晚期胆管癌

Goyal, Lipika; Meric-Bernstam, Funda; Hollebecque, Antoine; Valle, Juan W; Morizane, Chigusa; Karasic, Thomas B; Abrams, Thomas A; Furuse, Junji; Kelley, Robin Katie; Cassier, Philippe A; Klümpen, Heinz-Josef; Chang, Heung-Moon; Chen, Li-Tzong; Tabernero, Josep; Oh, Do-Youn; Mahipal, Amit; Moehler, Markus; Komatsu, Yoshito; Ahn, Daniel H; Epstein, Robert S; Halim, Abdel-Baset; Wacheck, Volker; He, Yaohua; Liu, Mei; Benhadji, Karim A; Bridgewater, John A

Oral Carbon Monoxide Enhances Autophagy Modulation in Prostate, Pancreatic, and Lung Cancers

口服一氧化碳可增强前列腺癌、胰腺癌和肺癌的自噬调节

Jianling Bi, Emily Witt, Megan K McGovern, Arielle B Cafi, Lauren L Rosenstock, Anna B Pearson, Timothy J Brown, Thomas B Karasic, Lucas C Absler, Srija Machkanti, Hannah Boyce, David Gallo, Sarah L Becker, Keiko Ishida, Joshua Jenkins, Alison Hayward, Alexandra Scheiflinger, Kellie L Bodeker, Rites

The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 after Progression on Rucaparib

Rucaparib治疗进展后,BRCA1、BRCA2或PALB2致病性变异晚期胰腺癌患者的逆转治疗的临床意义

Brown, Timothy J; Yablonovitch, Arielle; Till, Jacob E; Yen, Jennifer; Kiedrowski, Lesli A; Hood, Ryan; O'Hara, Mark H; Teitelbaum, Ursina; Karasic, Thomas B; Schneider, Charles; Carpenter, Erica L; Nathanson, Katherine; Domchek, Susan M; Reiss, Kim A

Precision Medicine and Immunotherapy Have Arrived for Cholangiocarcinoma: An Overview of Recent Approvals and Ongoing Clinical Trials

精准医疗和免疫疗法已应用于胆管癌的治疗:近期获批疗法和正在进行的临床试验概述

Karasic, Thomas B; Eads, Jennifer R; Goyal, Lipika

Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child-Pugh B cirrhosis

比较纳武利尤单抗和索拉非尼作为一线全身治疗方案在伴有Child-Pugh B级肝硬化的肝细胞癌患者中的疗效

Chapin, William J; Hwang, Wei-Ting; Karasic, Thomas B; McCarthy, Anne Marie; Kaplan, David E

Standards of Care for the Health of Transgender and Gender Diverse People, Version 8

跨性别者和性别多元人群健康护理标准,第8版

Coleman, E; Radix, A E; Bouman, W P; Brown, G R; de Vries, A L C; Deutsch, M B; Ettner, R; Fraser, L; Goodman, M; Green, J; Hancock, A B; Johnson, T W; Karasic, D H; Knudson, G A; Leibowitz, S F; Meyer-Bahlburg, H F L; Monstrey, S J; Motmans, J; Nahata, L; Nieder, T O; Reisner, S L; Richards, C; Schechter, L S; Tangpricha, V; Tishelman, A C; Van Trotsenburg, M A A; Winter, S; Ducheny, K; Adams, N J; Adrián, T M; Allen, L R; Azul, D; Bagga, H; Başar, K; Bathory, D S; Belinky, J J; Berg, D R; Berli, J U; Bluebond-Langner, R O; Bouman, M-B; Bowers, M L; Brassard, P J; Byrne, J; Capitán, L; Cargill, C J; Carswell, J M; Chang, S C; Chelvakumar, G; Corneil, T; Dalke, K B; De Cuypere, G; de Vries, E; Den Heijer, M; Devor, A H; Dhejne, C; D'Marco, A; Edmiston, E K; Edwards-Leeper, L; Ehrbar, R; Ehrensaft, D; Eisfeld, J; Elaut, E; Erickson-Schroth, L; Feldman, J L; Fisher, A D; Garcia, M M; Gijs, L; Green, S E; Hall, B P; Hardy, T L D; Irwig, M S; Jacobs, L A; Janssen, A C; Johnson, K; Klink, D T; Kreukels, B P C; Kuper, L E; Kvach, E J; Malouf, M A; Massey, R; Mazur, T; McLachlan, C; Morrison, S D; Mosser, S W; Neira, P M; Nygren, U; Oates, J M; Obedin-Maliver, J; Pagkalos, G; Patton, J; Phanuphak, N; Rachlin, K; Reed, T; Rider, G N; Ristori, J; Robbins-Cherry, S; Roberts, S A; Rodriguez-Wallberg, K A; Rosenthal, S M; Sabir, K; Safer, J D; Scheim, A I; Seal, L J; Sehoole, T J; Spencer, K; St Amand, C; Steensma, T D; Strang, J F; Taylor, G B; Tilleman, K; T'Sjoen, G G; Vala, L N; Van Mello, N M; Veale, J F; Vencill, J A; Vincent, B; Wesp, L M; West, M A; Arcelus, J

Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic Adenocarcinoma

包含循环肿瘤DNA和循环肿瘤细胞在内的多分析物预后特征在晚期胰腺腺癌患者中的应用

Chapin, William J; Till, Jacob E; Hwang, Wei-Ting; Eads, Jennifer R; Karasic, Thomas B; O'Dwyer, Peter J; Schneider, Charles J; Teitelbaum, Ursina R; Romeo, Janae; Black, Taylor A; Christensen, Theresa E; Redlinger Tabery, Colleen; Anderson, Amanda; Slade, Megan; LaRiviere, Michael; Yee, Stephanie S; Reiss, Kim A; O'Hara, Mark H; Carpenter, Erica L